Literature DB >> 4005390

Markov models for covariate dependence of binary sequences.

L R Muenz, L V Rubinstein.   

Abstract

Suppose that a heterogeneous group of individuals is followed over time and that each individual can be in state 0 or state 1 at each time point. The sequence of states is assumed to follow a binary Markov chain. In this paper we model the transition probabilities for the 0 to 0 and 1 to 0 transitions by two logistic regressions, thus showing how the covariates relate to changes in state. With p covariates, there are 2(p + 1) parameters including intercepts, which we estimate by maximum likelihood. We show how to use transition probability estimates to test hypotheses about the probability of occupying state 0 at time i (i = 2, ..., T) and the equilibrium probability of state 0. These probabilities depend on the covariates. A recursive algorithm is suggested to estimate regression coefficients when some responses are missing. Extensions of the basic model which allow time-dependent covariates and nonstationary or second-order Markov chains are presented. An example shows the model applied to a study of the psychological impact of breast cancer in which women did or did not manifest distress at four time points in the year following surgery.

Entities:  

Mesh:

Year:  1985        PMID: 4005390

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

2.  Exposure to respirable coalmine dust and incidence of progressive massive fibrosis.

Authors:  J F Hurley; W P Alexander; D J Hazledine; M Jacobsen; W M Maclaren
Journal:  Br J Ind Med       Date:  1987-10

3.  A nonstationary Markov transition model for computing the relative risk of dementia before death.

Authors:  Lei Yu; William S Griffith; Suzanne L Tyas; David A Snowdon; Richard J Kryscio
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

4.  Studies of acid aerosols in six cities and in a new multi-city investigation: design issues.

Authors:  F E Speizer
Journal:  Environ Health Perspect       Date:  1989-02       Impact factor: 9.031

5.  A comparative study of two statistical models for the analysis of binary data from longitudinal studies.

Authors:  H Origasa; J D Knoke
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

6.  Daily diaries of respiratory symptoms and air pollution: methodological issues and results.

Authors:  J Schwartz; D Wypij; D Dockery; J Ware; S Zeger; J Spengler; B Ferris
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

7.  Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women.

Authors:  Charles O Odongo; Kuteesa R Bisaso; Freddy Kitutu; Celestino Obua; Josaphat Byamugisha
Journal:  Malar J       Date:  2015-05-03       Impact factor: 2.979

8.  Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models.

Authors:  Awoke Seyoum Tegegne; Principal Ndlovu; Temesgen Zewotir
Journal:  BMC Infect Dis       Date:  2018-04-27       Impact factor: 3.090

Review 9.  Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Authors:  Elena Olariu; Kevin K Cadwell; Elizabeth Hancock; David Trueman; Helene Chevrou-Severac
Journal:  Clinicoecon Outcomes Res       Date:  2017-09-01

10.  Poverty dynamics, poverty thresholds and mortality: An age-stage Markovian model.

Authors:  Shayna Fae Bernstein; David Rehkopf; Shripad Tuljapurkar; Carol C Horvitz
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.